On this episode of BofC Live, we connect with Dr. Mather Carscallen, the CEO and CTO of Algae-C – a plant biosynthesis company using algae to create plant-derived active pharmaceutical ingredients (APIs) – including cannabinoids. Carscallen describes the process of using algae for biosynthesis and the value it has to the cannabis sector – including cost, consistency and environmental impact.BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.Learn more about Algae-C.